Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/11553
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ohyashiki, K | en_US |
dc.contributor.author | Kocova, M | en_US |
dc.contributor.author | Ryan, D H | en_US |
dc.contributor.author | Rowe, J M | en_US |
dc.contributor.author | Sandberg, A A | en_US |
dc.date.accessioned | 2021-03-25T11:03:59Z | - |
dc.date.available | 2021-03-25T11:03:59Z | - |
dc.date.issued | 1986-01-15 | - |
dc.identifier.issn | 0165-4608 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/11553 | - |
dc.description.abstract | Ph-positive acute myeloblastic leukemia (AML) developing in a treated case of Wegener's granulomatosis is reported. The patient was a 70-year-old white male who received cyclophosphamide (150 mg/day) starting in July 1978; in May 1984 the patient was diagnosed as having AML, following a diagnosis of myelodysplastic syndrome lasting 3 months. Cytogenetic study of bone marrow cells at the diagnosis of the myelodysplastic syndrome revealed a standard Ph translocation in addition to numerical chromosome changes [i.e., 45,XY, -5, -7, -8, +19, +mar/45,XY, -5, -7, -8, +19, +mar,t(9;22)(q34;q11]). The events in this case suggest a strong possibility of the Ph-positive AML being a secondary disease related to prior cyclophosphamide therapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER SCIENCE INC | en_US |
dc.relation.ispartof | Cancer genetics and cytogenetics | en_US |
dc.title | Secondary acute myeloblastic leukemia with a Ph translocation in a treated Wegener's granulomatosis | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/0165-4608(86)90062-2 | - |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 3-4 | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.